Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, November 20, 2015
Catalent Pharma Solutions has announced the multi-site expansion of its analytical and process development capabilities for biologics. These investments include a significant expansion of bioassay and protein characterization capabilities at its ...
read more
Friday, November 20, 2015
Mylan has announced the U.S. launch of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (mixed salts of a single entity amphetamine product), 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg, 20 mg and...
read more
Thursday, November 19, 2015
Merck and Pfizer today have announced that the US Food and Drug Administration (FDA) has granted avelumab, an investigational fully human anti-PD-L1 IgG1 monoclonal antibody, Breakthrough Therapy designation for the treatment of patients with ...
read more
Thursday, November 19, 2015
Purdue Pharma has announced the appointment of Alan W. Dunton, M.D. to the position of Senior Vice President of Research & Development (R&D) and will report to Chief Executive Officer Mark Timney.
read more
Thursday, November 19, 2015
Ipsen, a global specialty driven pharmaceutical group, and Interprotein Corporation, a Japanese R&D focused biotechnology company, have signed a research collaboration and an option agreement to develop and commercialize new therapeutic peptides ...
read more
Thursday, November 19, 2015
Charles River Laboratories International has acquired Oncotest GmbH, a Freiburg, Germany-based contract research organization (CRO) providing discovery services for oncology, one of the largest therapeutic areas for biopharmaceutical research and ...
read more
Thursday, November 19, 2015
Gurnet Point Capital, an investment firm focused on the healthcare and life sciences sectors that was founded by Ernesto Bertarelli and is led by Christopher A. Viehbacher, has announced the creation of Boston Pharmaceuticals.
read more
Thursday, November 19, 2015
Bilcare Research Inc., one of the world’s largest manufacturers of blister packaging solutions, has hired Anna Frolova-Levi as Vice President of Sales & Marketing.
read more
Wednesday, November 18, 2015
Sandoz, a Novartis company, has announced today the US Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) under the 351 (k) pathway for its proposed biosimilar to Amgen's US-licensed Neulasta® (pegfilgrastim)* - a...
read more
Wednesday, November 18, 2015
PAREXEL International Corporation has announced the enhancement of its end-to-end clinical development services through its new process, called Clinical Development Optimization.
read more
Wednesday, November 18, 2015
Alphora is pleased to announce the completion of a new 3,000 sq. ft. analytical laboratory expansion.
read more
Wednesday, November 18, 2015
Responding to the billions of advertising dollars being spent to promote prescription products, physicians at the Interim Meeting of the American Medical Association (AMA) adopted a new policy aimed at driving solutions to make prescription drugs ...
read more
Wednesday, November 18, 2015
Merck KGaA, Darmstadt, Germany, has announced the completion of its $17 billion acquisition of Sigma-Aldrich.
read more
Friday, November 13, 2015
Paragon Bioservices, a global manufacturer of biopharmaceuticals and vaccines, has announced the appointment of Robert Roche to the Company's Board of Directors.
read more
Thursday, November 12, 2015
BioDuro, a global CRO focused on preclinical chemistry, biology, and fully outsourced integrated drug development services for pharmaceutical partners, announced the merger of its US operations with Formex, LLC, a provider of pharmaceutical API ...
read more